Results 121 to 130 of about 114,353 (299)
Vaccinations During Pregnancy Protect the Mother–Infant Dyad and Are Generally Safe
ABSTRACT Aim Vaccination in pregnancy has a critical impact on mothers, foetuses and infants. The aim of this paper was to summarise key points presented by experts attending the 12th Maria Delivoria‐Papadopoulos Perinatal Symposium in March 2025 and further expand and update them.
Ariadne Malamitsi‐Puchner +2 more
wiley +1 more source
Critical role of the mast cell/tryptase/PAR2 axis in anastrozole‐induced pain
Abstract Background and Purpose Anastrozole, an aromatase inhibitor, is used to treat postmenopausal women with hormone receptor‐positive breast cancer, but also induces musculoskeletal pain and can lead to therapeutic regimen suspension. Aromatase inhibitors promote the release of pro‐inflammatory substances from sensitised nerve fibres, which might ...
Maria Fernanda Pessano Fialho +5 more
wiley +1 more source
Human T-lymphotropic virus 1 (HTLV-1) infection has been associated with inflammatory, autoimmune, and lymphoproliferative diseases with a wide spectrum of clinical manifestations.
Márcio Yutaka Tsukimata +19 more
doaj +1 more source
Background and Purpose Whereas the effects of Trypanosoma cruzi (T. cruzi) infection are well‐characterised in the heart, its impact on the vasculature has received little attention. In this study, we investigated the effects of acute and chronic T. cruzi infection on vascular responsiveness and the underlying mechanisms.
Thales M. H. Dourado +6 more
wiley +1 more source
Some evidences about Crimean Congo Hemorrhagic Fever [PDF]
[No abstract ...
Abbasi, A., Besharat, S., Jabbari, A.
core
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos +16 more
wiley +1 more source
Pharmacotherapeutics of Musculoskeletal Orofacial Pain
Background Musculoskeletal orofacial pain is an umbrella term for pain in the masticatory muscles, temporomandibular joint and their associated tissues.
Brian E. Cairns, Sujay A. J. Mehta
doaj +1 more source
Ramucirumab (RAM) plus docetaxel (DOC) after PD‐1 inhibitors showed clinical activity, with responders exhibiting maintained anti–PD‐1 (IgG4+)‐bound CD8+ T cells and decreased IgG4+ Tregs. A sequential strategy of administering RAM plus DOC during persistent anti–PD‐1 antibody binding may be beneficial in patients with advanced non‐small cell lung ...
Kinnosuke Matsumoto +20 more
wiley +1 more source
Aims and Objectives: To determine the incidence, spectrum, and predictors of musculoskeletal (MSK) disorders among patients initiated on statins.
Mushtaq Ahmad Dangroo +7 more
doaj +1 more source
EPI Update, August 6, 2010 [PDF]
Weekly newsletter for Center For Acute Disease Epidemiology of Iowa Department of Public ...
core

